The purpose of this study is to determine whether a neuropeptide, substance P, when injected along with an allergen, such as ragweed, can reduce allergic reactivity.
Allergic Rhinitis (Hay fever) affects many children and adults and is a risk factor for development of asthma. This study utilizes the neurotransmitter, substance P, a small molecule which is present in nerve endings, the brain, skin, lungs and the gastrointestinal tract. Subjects will receive substance P and a low dosage of an allergen, such as ragweed in an attempt to reduce allergic reactivity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
injections of substance P and low dose allergen or placebo
injections of substance P for 8 weeks
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
CBER ID50 skin test result
The ID50 skin test result utilizes FDA CBER methodology to determine the change in allergic skin reactivity to ragweed and grass pollen allergens.
Time frame: 1 to 6 months after completing injections
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.